 | Up a level |
Gerger, Armin; Eisterer, Wolfgang; Fuxius, Stefan; Bastian, Sara; Koeberle, Dieter; Welslau, Manfred; Akhoundova Sanoyan, Dilara; Maas, Christian; Uhlig, Jens; Fenchel, Klaus; Greil, Richard; von der Heyde, Eyck; Rhyner Agocs, Gaëlle; Weide, Rudolf; Schwager, Monika; Reichenbach, Frank; Modest, Dominik Paul; Fritsch, Ralph (2022). Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC. Anticancer research, 42(10), pp. 4773-4785. International Inst. of Anticancer Research 10.21873/anticanres.15982
Kienle, Dirk L.; Dietrich, Daniel; Ribi, Karin; Wicki, Andreas; Quagliata, Luca; Winterhalder, Ralph C.; Koeberle, Dieter; Horber, Daniel; Bastian, Sara; Kueng, Marc; Saletti, Piercarlo; Helbling, Daniel; Baertschi, Daniela; Lugli, Alessandro; Bernhard, Jürg; Andrieu, Christiane; von Moos, Roger (2019). Cetuximab monotherapy and cetuximab plus capecitabine as first-line treatment in older patients with RAS- and BRAF wild-type metastatic colorectal cancer. Results of the multicenter phase II trial SAKK 41/10. Journal of geriatric oncology, 10(2), pp. 304-310. Elsevier 10.1016/j.jgo.2018.11.011
von Moos, Roger; Koeberle, Dieter; Schacher, Sabina; Hayoz, Stefanie; Winterhalder, Ralph C; Roth, Arnaud; Bodoky, György; Samaras, Panagiotis; Berger, Martin D.; Rauch, Daniel; Saletti, Piercarlo; Plasswilm, Ludwig; Zwahlen, Daniel; Meier, Urs R; Yan, Pu; Izzo, Paola; Klingbiel, Dirk; Bärtschi, Daniela; Zaugg, Kathrin (2018). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). European journal of cancer, 89, pp. 82-89. Elsevier 10.1016/j.ejca.2017.11.005
Ruhstaller, Thomas; Templeton, Arnoud; Ribi, Karin; Schuller, Jan C; Borner, Markus; Thierstein, Sandra; von Moos, Roger; Pederiva, Stefanie; Lohri, Andreas; Lombriser, Norbert; von Briel, Christian; Koeberle, Dieter; Popescu, Razvan (2010). Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02). Onkologie, 33(5), pp. 222-8. Basel: Karger 10.1159/000305094
Koeberle, Dieter; Montemurro, Michael; Samaras, Panagiotis; Majno, Pietro; Simcock, Mathew; Limacher, Andreas; Lerch, Stefanie; Kovàcs, Katalin; Inauen, Roman; Hess, Vivianne; Saletti, Piercarlo; Borner, Markus; Roth, Arnaud; Bodoky, György (2010). Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06). Oncologist, 15(3), pp. 285-92. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2009-0316
Ribi, Karin; Koeberle, Dieter; Schuller, Jan C; Honegger, Hanspeter; Roth, Arnaud; Hess, Viviane; Moosmann, Peter; von Moos, Roger; Borner, Markus; Lombriser, Norbert; Pestalozzi, Bernhard; Ruhstaller, Thomas (2009). Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation? Supportive care in cancer, 17(8), pp. 1109-1116. Berlin: Springer 10.1007/s00520-008-0570-6
Koeberle, Dieter; Saletti, Piercarlo; Borner, Markus; Gerber, Daniela; Dietrich, Daniel; Caspar, Clemens B; Mingrone, Walter; Beretta, Kurt; Strasser, Florian; Ruhstaller, Thomas; Mora, Oreste; Herrmann, Richard (2008). Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology, 26(22), pp. 3702-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2008.16.5704
Bernhard, Jürg; Dietrich, Daniel; Scheithauer, Werner; Gerber, Daniela; Bodoky, György; Ruhstaller, Thomas; Glimelius, Bengt; Bajetta, Emilio; Schüller, Johannes; Saletti, Piercarlo; Bauer, Jean; Figer, Arie; Pestalozzi, Bernhard C; Köhne, Claus-Henning; Mingrone, Walter; Stemmer, Salomon M; Tàmas, Karin; Kornek, Gabriela V; Koeberle, Dieter; Herrmann, Richard; ... (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, 26(22), pp. 3695-701. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.15.6240
Koeberle, Dieter; Betticher, Daniel; Von Moos, Roger; Dietrich, Daniel; Brauchli, Peter; Baertschi, Daniela; Matter-Walstra, Klazien; Winterhalder, Ralph; Borner, Markus; Anchisi, Sandro; Moosmann, Peter; Kollár, Attila; Saletti, Piercarlo; Roth, Arnaud; Frueh, Martin; Kueng, Marc; Popescu, Razvan; Schacher, Sabina; Hess, Viviane and Herrmann, Richard (2013). O-0028 Bevacizumab Continuation Versus No Continuation After First-Line Chemo-Bevacizumab Therapy in Patients with Metastatic Colorectal Cancer: a Phase 3 Non-Inferiority Trial. Annals of oncology, 24(Suppl 4), iv22-iv22. Oxford University Press 10.1093/annonc/mdt201.28
